Literature DB >> 7567935

Keratin 20: immunohistochemical marker for gastrointestinal, urothelial, and Merkel cell carcinomas.

M Miettinen1.   

Abstract

Keratin 20 is a recently identified keratin protein distributed particularly in the epithelial cells of the gastrointestinal tract. In this study, keratin 20 was immunohistochemically evaluated in 788 epithelial tumors of different organs. Keratin 20 was consistently present in colonic adenocarcinomas and their metastases in lymph nodes, liver, lung, and ovaries; most primary and metastatic colon carcinomas showed high numbers of positive cells independent of their level of differentiation. Adenocarcinomas of the upper gastrointestinal tract, pancreas, and cholangiocarcinomas showed variable reactivity. Hepatocellular carcinomas and carcinoid tumors often showed focal reactivity limited to scattered tumor cells. In contrast, keratin 20 was virtually absent in primary adenocarcinomas of lung, ovaries, and endometrium. Notable exceptions among ovarian tumors were the mucinous neoplasms that showed variable, sometimes significant keratin 20 reactivity. Transitional cell carcinomas irrespective of grade were usually positive, whereas most prostatic and renal adenocarcinomas were negative or showed only single positive cells. Typically negative were squamous cell carcinomas of all organs and carcinomas of the breast. Merkel cell carcinomas of the skin showed consistent reactivity, whereas small cell carcinomas of the lung were negative. On the basis of these observations, keratin 20 seems to be a suitable adjunct marker to evaluate the primary origin of carcinomas in specific contexts, especially to separate adenocarcinomas of gastrointestinal versus nongastrointestinal origin.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7567935

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  29 in total

1.  Cytokeratin CK 7 and CK 20 expression in pituitary adenomas.

Authors:  Stephen W Coons; Sarah I Estrada; Ruben Gamez; William L White
Journal:  Endocr Pathol       Date:  2005       Impact factor: 3.943

Review 2.  Immunohistochemistry of soft tissue tumours - review with emphasis on 10 markers.

Authors:  Markku Miettinen
Journal:  Histopathology       Date:  2013-11-28       Impact factor: 5.087

Review 3.  Developing a sense of touch.

Authors:  Blair A Jenkins; Ellen A Lumpkin
Journal:  Development       Date:  2017-11-15       Impact factor: 6.868

Review 4.  The Emerging Role of Inflammasomes as Central Mediators in Inflammatory Bladder Pathology.

Authors:  Brian M Inouye; Francis M Hughes; Stephanie J Sexton; J Todd Purves
Journal:  Curr Urol       Date:  2017-12-30

5.  Limitations of cytokeratin 20 RT-PCR to detect disseminated tumour cells in blood and bone marrow of patients with colorectal cancer: expression in controls and downregulation in tumour tissue.

Authors:  F A Vlems; J H S Diepstra; I M H A Cornelissen; T J M Ruers; M J L Ligtenberg; C J A Punt; J H J M van Krieken; Th Wobbes; G N P van Muijen
Journal:  Mol Pathol       Date:  2002-06

6.  Expression of keratin 20 and its clinicopathological significance in intrahepatic cholangiocarcinoma.

Authors:  Ji Eun Choi; Sang Jae Noh; Ju Hyung Lee; Jun Sang Bae; Hyun Hee Chu; Ho Sung Park; Kyu Yun Jang; Myoung Ja Chung; Myoung Jae Kang; Dong Geun Lee; Woo Sung Moon
Journal:  Oncol Lett       Date:  2012-06-13       Impact factor: 2.967

7.  Differentiating the undifferentiated: immunohistochemical profile of medullary carcinoma of the colon with an emphasis on intestinal differentiation.

Authors:  Brody Winn; Rosemarie Tavares; Jacqueline Fanion; Lelia Noble; John Gao; Edmond Sabo; Murray B Resnick
Journal:  Hum Pathol       Date:  2008-11-07       Impact factor: 3.466

8.  Keratin immunohistochemistry in renal cell carcinoma subtypes and renal oncocytomas: a systematic analysis of 233 tumors.

Authors:  Cord Langner; Beate J Wegscheider; Manfred Ratschek; Luigi Schips; Richard Zigeuner
Journal:  Virchows Arch       Date:  2004-01-16       Impact factor: 4.064

9.  The value of combined use of survivin, cytokeratin 20 and mucin 7 mRNA for bladder cancer detection in voided urine.

Authors:  Xiao-Yong Pu; Zhi-Ping Wang; Yi-Rong Chen; Xing-Huan Wang; Yi-Long Wu; Huai-Peng Wang
Journal:  J Cancer Res Clin Oncol       Date:  2007-11-20       Impact factor: 4.553

10.  Which urine marker test provides more diagnostic value in conjunction with standard cytology- ImmunoCyt/uCyt+ or Cytokeratin 20 expression.

Authors:  Isin Soyuer; Mustafa Sofikerim; Fatma Tokat; Serdar Soyuer; Figen Ozturk
Journal:  Diagn Pathol       Date:  2009-06-26       Impact factor: 2.644

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.